04/01/2025
11:15 PM | Nektar Therapeutics (Filer)
| Form EFFECT | |
03/28/2025
3:22 PM | Nektar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2025
3:22 PM | Nektar Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2025
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
6:10 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
5:04 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:06 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
2:27 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:18 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:21 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for NKTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
12:49 PM | Nektar Therapeutics (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
11:08 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:43 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/17/2025
7:37 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:39 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:30 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:32 PM | Brainard Diana (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:35 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
12/26/2024
6:04 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
8:35 AM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
2:21 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
7:33 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
8:08 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
2:12 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:17 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
7:54 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:54 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:55 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
2:29 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
8:24 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
7:37 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:36 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:36 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
2:17 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
2:28 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
11:17 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:18 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/07/2024
3:31 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:52 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) My friends Joel and Adam have a simple motto: "For us, it's always a bull market."
That’s because their 92% win rate trading system is built to profit in any market – whether Bitcoin is mooning, correcting, or chopping sideways.
No more guessing. No more stress. Just precision trades that put you in control. >> See How In Their FREE Workshop |
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:13 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
2:45 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
5:02 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
11:15 PM | Nektar Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
4:30 PM | Nektar Therapeutics (Filer)
| Form 424B3 | |
05/28/2024
3:51 PM | Nektar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/20/2024
8:12 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
8:13 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:36 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:12 PM | Nektar Therapeutics (Filer)
| Form ARS | |
04/17/2024
4:03 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
